CommercialAdministrativeMedium impact
Policy Criteria Change
Arkansas Blue Cross Blue Shield·AR · Endocrinology, Oncology, Dermatology·Medical Policy
Effective date
Jun 15, 2026
We identified it
Jun 19, 2026
Summary
Arkansas Blue Cross is archiving three medical policies effective June 15, 2026: Chronic Intermittent Insulin Therapy, Hepsin Biomarker Testing, and Mohs Micrographic Surgery. These policies will no longer be active for coverage determinations after this date.
Action Required
By June 15, 2026: Billing team must review current billing practices for chronic intermittent insulin therapy, hepsin biomarker testing, and Mohs micrographic surgery. Contact Arkansas Blue Cross to understand replacement coverage criteria or alternative policies that will govern these services after archival date.